OBJECTIVE: To evaluate both the patterns of prescription of androgen deprivation therapy (ADT) in patients with prostate cancer (PCa) and the adherence to European Association of Urology (EAU) guidelines for ADT prescription. METHODS: The Choosing Treatment for Prostate Cancer (CHOICE) study was an Italian multicentre cross-sectional study conducted between December 2010 and January 2012. A total of 1 386 patients, treated with ADT for PCa (first prescription or renewal of ADT), were selected. With regard to the EAU guidelines on ADT, the cohort was categorized into discordant ADT (Group A) and concordant ADT (Group B). RESULTS: The final cohort included 1 075 patients with a geographical distribution including North Italy (n = 627, 58.3%...
International audienceThe safety profile of androgen deprivation therapy (ADT) is well known, and ca...
Open Access via the Elsevier Agreement We are grateful to the EAU Research Foundation for funding th...
Background There are several treatments available to newly diagnosed prostate cancer (PCA) patients....
To evaluate both the patterns of prescription of androgen deprivation therapy (ADT) in patients with...
ObjectiveTo evaluate both the patterns of prescription of androgen deprivation therapy (ADT) in pati...
Background: Evidence-practice gaps exist in urology. We previously surveyed European Association of ...
Background: Guidelines on androgen deprivation therapy (ADT) for prostate cancer (PCa) arise from a ...
Background: According to (inter-)national guidelines, (neo-)adjuvant and concurrent androgen depriva...
OBJECTIVE: To analyze the prevalence of cardiovascular disease (CVD) and osteoporosis in patients tr...
OBJECTIVE To analyze the prevalence of cardiovascular disease (CVD) and osteoporosis in patients tre...
Objective To analyze the prevalence of cardiovascular disease (CVD) and osteoporosis in patients tre...
Background: Androgen deprivation therapy (ADT) is a non-curative but essential treatment of prostate...
International audienceThe safety profile of androgen deprivation therapy (ADT) is well known, and ca...
Open Access via the Elsevier Agreement We are grateful to the EAU Research Foundation for funding th...
Background There are several treatments available to newly diagnosed prostate cancer (PCA) patients....
To evaluate both the patterns of prescription of androgen deprivation therapy (ADT) in patients with...
ObjectiveTo evaluate both the patterns of prescription of androgen deprivation therapy (ADT) in pati...
Background: Evidence-practice gaps exist in urology. We previously surveyed European Association of ...
Background: Guidelines on androgen deprivation therapy (ADT) for prostate cancer (PCa) arise from a ...
Background: According to (inter-)national guidelines, (neo-)adjuvant and concurrent androgen depriva...
OBJECTIVE: To analyze the prevalence of cardiovascular disease (CVD) and osteoporosis in patients tr...
OBJECTIVE To analyze the prevalence of cardiovascular disease (CVD) and osteoporosis in patients tre...
Objective To analyze the prevalence of cardiovascular disease (CVD) and osteoporosis in patients tre...
Background: Androgen deprivation therapy (ADT) is a non-curative but essential treatment of prostate...
International audienceThe safety profile of androgen deprivation therapy (ADT) is well known, and ca...
Open Access via the Elsevier Agreement We are grateful to the EAU Research Foundation for funding th...
Background There are several treatments available to newly diagnosed prostate cancer (PCA) patients....